Kayne Anderson Rudnick Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24	Closed	-$3K	–	705
2022 Q1	$3K	Buy	+24	New	+$3K	﹤0.01%	590
2021 Q1	–	Sell	-4	Closed	–	–	755
2020 Q4	$0	Buy	+4	New	–	﹤0.01%	735